Skip to main content
Top
Gepubliceerd in: Quality of Life Research 3/2015

Open Access 01-03-2015

Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China

Auteurs: Sun Sun, Jiaying Chen, Paul Kind, Ling Xu, Yaoguang Zhang, Kristina Burström

Gepubliceerd in: Quality of Life Research | Uitgave 3/2015

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
insite
ZOEKEN

Abstract

Purpose

To investigate the feasibility of deriving experience-based visual analogue scale (VAS) values for EQ-5D-3L health states using national general population health survey data in China.

Methods

The EQ-5D-3L was included in the National Health Services Survey (n = 120,709, aged 15–103 years) to measure health-related quality of life. The respondents reported their current health status on a VAS and completed the EQ-5D-3L questionnaire, enabling modelling of the association between the experience-based VAS values and self-reported problems on EQ-5D dimensions and severity levels.

Results

VAS values were generally negatively associated with problems reported on the EQ-5D dimensions, and the anxiety/depression dimension had the greatest impact on VAS values. A previously obtained value for dead allowed the values for all 243 EQ-5D-3L health states to be transformed to the 0–1 scale (0 = dead, 1 = full health).

Conclusions

This study presents the feasibility of deriving an experience-based VAS values for EQ-5D-3L health states in China. The analysis of these VAS data raises more fundamental issues concerning the universal nature of the classification system and the extent to which Chinese respondents utilise the same concepts of health as defined by this classification system.
Opmerkingen

Electronic supplementary material

The online version of this article (doi:10.​1007/​s11136-014-0793-6) contains supplementary material, which is available to authorized users.
Afkortingen
QALY
Quality-adjusted life year
HRQoL
Health-related quality of life
NHSS
National Health Services Survey
SG
Standard gamble
RS
Rating scale
VAS
Visual analogue scale
TTO
Time trade-off
OLS
Ordinary least square
MAD
Mean absolute difference
SCC
Spearman rank correlation coefficients

Background

EQ-5D is a widely used generic health-related quality of life (HRQoL) instrument [1], with applications in clinical studies, economic evaluation of health care [2] and in population health surveys [3]. It is recommended by the UK National Health Service (NHS) as a health outcomes measure for use by clinicians and managers [4]. In China, there is an increasing interest in applying EQ-5D, both amongst patients [5, 6] and the general population [710]. EQ-5D-3L (with five dimensions and three severity levels) defines a classification of 243 health states and was included in the National Health Services Survey (NHSS) 2008 in China, and population norms have been established by age, sex, socioeconomic status [8] and geographic area [9].
EQ-5D-3L health states represent a nominal level of measurement since they cannot be ordered and have no intrinsic quantitative score. In order to convert such a classification into a cardinal scale with true arithmetic properties, it is necessary to devise a system whereby individual health states can be assigned an index value. Methods for deriving scores for use in economic evaluation must take into account several important methodological considerations, in particular, which valuation method should be used and whose values should be applied. Many methods have been used to obtain health state values including: standard gamble (SG), time trade-off (TTO) and rating scale (RS) [2]. Both TTO and RS (visual analogue scale (VAS)) have been used for obtaining EQ-5D value sets [11, 12], and recently, the discrete choice method was tested [13]. However, none of these methods is recognised as being the standard measure for valuing health in economic evaluations [2, 14].
Similarly, there are differences of opinion as to whose values should be used [1417]: experience-based values are based on assessments made by individuals who are actually in the health state; hypothetical values are based on assessments of health state descriptions. Experience-based values for EQ-5D-3L health states have been investigated, both for TTO [16, 18, 19] and VAS [16, 18, 2022]. Previous studies have shown that the experience-based values tend to be higher than hypothetical values [15, 16, 2228], and the anxiety/depression dimension seems to be more important when values are experience-based [16, 2225]. For EQ-5D valuation studies based on hypothetical values, in general, the VAS values are higher than those using TTO values [12, 29]. As far as is known, only two studies [16, 18] have reported both TTO and VAS values from the same respondents using experience-based values.
The aim of the present study is to investigate the feasibility of deriving experience-based VAS values for EQ-5D-3L health states using national general population health survey data in China.

Materials and methods

Material/study population

Data are obtained from the National Health Services Survey 2008 (NHSS 2008), which is organised by the Ministry of Health (MoH). A multi-stage stratified cluster random sampling method was used, in total, 177,051 respondents were face-to-face interviewed. Of these, about 18 % aged below 15 years were excluded. Respondents needing assistance in answering questions were excluded (13 %) as were those who had missing answers on age, sex, in at least one of the EQ-5D dimensions and on VAS. These accounted for a further 2 %. For 6 respondents with a profile of 11111 and VAS higher than 100, their VAS value were imputed as 100. After applying these criteria, 120,709 respondents were available for further study. The NHSS sampling design was examined by the MoH for all waves of the surveys, and the representativeness of the sample was considered good, i.e., proportions of the population from different regions, age, sex and socio-economic structures are representative of the Chinese population and are similar to the census data, except for the unemployment rate, which might be due to different ways of defining unemployment [30].
Details regarding questionnaire, sampling method, interview procedure can be found elsewhere [8, 9]. The value for dead was obtained from the Household Health Survey 2010 (n = 8,031), which used a similar protocol as the NHSS 2008.
The EQ-5D-3L instrument classifies respondents’ health status in five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), with three severity levels (no problems, some problems and severe problems), which in total defines 243 health states [1]. The VAS consisted of a horizontal 11 cm line where every tenth was marked and labelled 0, 10, 20, …, 100, with anchor points 0 (worst health state) and 100 (best health state). The question was framed: ‘On the scale please point out which point best represents your own health state today’. Respondents were asked to record their value for the state ‘dead’ using the same VAS. The question was framed: ‘This scale is the same as the one you saw before. On this scale, where would you score dead?’ The scale was harmonised to fit in the NHSS questionnaire and hence differs from the EQ VAS.
Ethical permissions have been granted by the Regional Ethics Committee, Stockholm, Sweden for the studies (Dnr: 2009/1892-31/5, for NHSS 2008; Dnr: 2011/581- 31/5, for HHS 2010).

Data analyses

All statistical analyses were performed using SAS version 9.2 [31], using a 5 % significance level. Ordinary least square (OLS) was used for all regression analysis. Definition of variables and models are presented in Table 1. A structured approach to data analysis was taken in which a basic main effects model was specified using two dummy variables for each of the five dimensions. The performance of alternative models was examined in which interaction terms were included with a view to improving model performance. Interaction terms were included as follows: if any dimension is on level 2 or 3 (N2 and N3, respectively), number of dimensions at level 2 or 3 beyond the first one and the square term of it. However, only N3 leads to consistent results, and therefore, we only present models with N3 term.
Table 1
Definition of variables and models
Variable
Definition
MO2
1 If mobility is level 2; 0 otherwise
MO3
1 If mobility is level 3; 0 otherwise
SC2
1 If self-care is level 2; 0 otherwise
SC3
1 If self-care is level 3; 0 otherwise
SC3*
1 If self-care is level 3; 0 otherwise (merged levels 1 and 2 in the reference group)
SC23
1 If self-care is level 2 or 3; 0 otherwise
UA2
1 If usual activities is level 2; 0 otherwise
UA3
1 If usual activities is level 3; 0 otherwise
PD2
1 If pain/discomfort is level 2; 0 otherwise
PD3
1 If pain/discomfort is level 3; 0 otherwise
AD2
1 If anxiety/depression is level 2; 0 otherwise
AD3
1 If anxiety/depression is level 3; 0 otherwise
N3
1 If any dimension is level 3; 0 otherwise
Models
f(x)
Models based on individual data
Model 1
f (mo2 mo3 sc2 sc3 ua2 ua3 pd2 pd3 ad2 ad3)
Model 2
f (mo2 mo3 sc2 sc3 ua2 ua3 pd2 pd3 ad2 ad3 N3)
Model 3
f (mo2 mo3 sc3* ua2 ua3 pd2 pd3 ad2 ad3)
Model 4
f (mo2 mo3 sc3* ua2 ua3 pd2 pd3 ad2 ad3 N3)
Model 5
f (mo2 mo3 sc23 ua2 ua3 pd2 pd3 ad2 ad3)
Model 6
f (mo2 mo3 sc23 ua2 ua3 pd2 pd3 ad2 ad3 N3)
Models based on aggregated data
Model 1M1–Model 1M3
f (mo2 mo3 sc2 sc3 ua2 ua3 pd2 pd3 ad2 ad3)
A primary requirement for any estimation model is that coefficients are monotonically consistent within dimensions so that value loss increases as the level of problem becomes greater. Firstly, we tested the models with the ten dummy variables (Model 1). However, the coefficient for moderate problems on self-care dimension (SC2) was positive; therefore, we tested N3 term, but SC2 was still positive. Two further sets of models were tested. In Models 3 and 4, SC2 was excluded, and thus for self-care dimension, the levels 1 and 2 were merged into one category in the reference group and the coefficient for self-care level 3 was then represented by SC3*. In Models 5 and 6, for self-care dimension, the levels 2 and 3 were merged into one category, by including a new dummy variable SC23. F-tests were used to make comparisons between the models with and without the N3 term.
For models based on individual-level data, raw VAS value was used as the dependant variable in the OLS models. Due to the skewed distribution of data, we have tested OLS models with log-transformed VAS [32]. Furthermore, we also performed Poisson, negative binomial [21, 33], Tobit [34] and quantile models [35]. However, compared with the OLS models, these did not provide better results, in terms of monotonicity and goodness of fit; therefore, we only present OLS models with raw VAS value.
The survey dataset contains multiple ratings from separate individuals who classify themselves in the same EQ-5D health state. For these health states, it is possible to compute a mean rating which represents the average VAS value associated with that specific health state. Step-wise sensitive analyses were taken, to investigate how many observations were required in order to generate a ‘safe’ mean for each EQ-5D health state (results can be provided on request). In this study, EQ-5D health states with 20 or more observations were considered reasonable. Aggregate-level analyses were carried out using models in which mean VAS value for these health states were taken as the dependent variable and the ten main effect dummy variables as the independent variables.
Selection of the final models is based on the following criteria [36]: the model should be simple (parsimony), should provide consistent results with an acceptable goodness of fit and should be transparent so as to be able to be understood by non-experts. Spearman rank correlation coefficients (SCC) and mean absolute difference (MAD) were used to examine the goodness of fit of the models. Higher SCC and lower MAD indicates better model fitting.
We employed a split sample test in order to estimate the robustness of the final model. Furthermore, we explored the effect of socio-demographic factors on health state valuation. Details regarding the above analyses can be found in online resource (QURE-S-14-00050_ESM.pdf).

Results

Characteristics of the sample, percentage of problems reported on each EQ-5D dimension and mean VAS score are presented in Table 2.
Table 2
Characteristics of the respondents
 
15–103 years (n = 120,709)
%
n
Sex
Men
48.2
58,169
Women
51.8
62,540
Age group (years)
15–24
11.3
13,635
25–34
13.7
16,510
35–44
23.3
28,088
45–54
21.3
25,695
55–64
16.2
19,557
65–74
9.5
11,491
75–103
4.8
5,733
Region
Urban
27.7
33,447
Rural
72.3
87,262
Area
Eastern
35.1
42,305
Middle
27.5
33,175
Western
37.5
45,229
Marital status
Single
11.9
14,406
Married
79.2
95,649
Divorced
1.4
1,744
Widowed
7.1
8,605
Other
0.2
234
Missing
0.1
71
Educational level
Below primary school
15.6
18,841
Primary school
27.9
33,630
Junior middle school
35.7
43,042
Senior middle school
14.9
17,941
College and above
5.9
7,160
Missing
0.1
95
Income groups
First group (low)
22.8
27,560
Second group
21.6
26,037
Third group
18.9
22,791
Fourth group
17.7
21,417
Fifth group (high)
19.0
22,904
Occupational status
Employed
70.6
85,161
Retired
10.2
12,313
Student
4.4
5,322
Unemployed
14.6
17,627
Missing
0.2
286
EQ-5D dimension
Mobility
Moderate problems (level 2)
4.8
5,760
Severe problems (level 3)
0.4
447
Self-care
Moderate problems (level 2)
2.8
3,413
Severe problems (level 3)
0.4
522
Usual activities
Moderate problems (level 2)
4.0
4,850
Severe problems (level 3)
0.8
978
Pain/discomfort
Moderate problems
8.8
10,661
Severe problems
0.4
500
Anxiety/depression
Moderate problems (level 2)
6.0
7,287
Severe problems (level 3)
0.4
467
 
Mean
SD
VAS score
80.1
14.1
The observed EQ-5D health states are presented in online resource Supplementary Table S1. In total, 167 out of the 243 possible EQ-5D health states were observed and 51 health states had 20 or more observations. The most frequently occurred health state was 11111 (87 % of the population), followed by 11121 and 11112. The mean VAS value for 11111 was 82.6, which was 17 points below the upper boundary of best health state. The mean VAS value for 33333 was 34, which was 34 points above the lower bound of worst health state.
Table 3 shows the coefficients produced by OLS based on individual-level data. Models 1 and 2 included all the ten dummy variables; the coefficients were monotonic except for SC2. In Models 3 and 4, all coefficients were monotonic. In Models 5 and 6, coefficient for self-care dimension and N3 were positive. In Model 4, the N3 terms were negative and significant. However, the F-test did not suggest that the Model 4 was significantly better than Model 3.
Table 3
Regression analysis on VAS values and EQ-5D dimensions, individual-level data
 
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Estimate
p value
Estimate
p value
Estimate
p value
Estimate
p value
Estimate
p value
Estimate
p value
Intercept
82.39
<0.0001
82.39
<0.0001
82.39
<0.0001
82.39
<0.0001
82.39
<0.0001
82.39
<0.0001
Mobility
 Level 2
−6.55
<0.0001
−6.53
<0.0001
−6.39
<0.0001
−6.35
<0.0001
−6.52
<0.0001
−6.49
<0.0001
 Level 3
−8.36
<0.0001
−8.10
<0.0001
−8.13
<0.0001
−7.86
<0.0001
−9.48
<0.0001
−9.23
<0.0001
Self-care
 Level 2
0.74
0.0212
0.80
0.0126
 Level 3
−2.69
0.0008
−2.66
0.0009
 Level 3a
−3.21
<0.0001
−3.22
<0.0001
 Level 2 and 3
0.57
0.76
0.63
0.0500
Usual activities
 Level 2
−6.18
<0.0001
−6.14
<0.0001
−5.89
<0.0001
−5.83
<0.0001
−6.11
<0.0001
−6.07
<0.0001
 Level 3
−11.53
<0.0001
−8.93
<0.0001
−11.21
<0.0001
−8.64
<0.0001
−12.49
<0.0001
−9.91
<0.0001
Pain/discomfort
 Level 2
−11.07
<0.0001
−11.04
<0.0001
−11.07
<0.0001
−11.04
<0.0001
−11.06
<0.0001
−11.04
<0.0001
 Level 3
−13.98
<0.0001
−12.76
<0.0001
−13.98
<0.0001
−12.78
<0.0001
−14.34
<0.0001
−13.13
<0.0001
Anxiety/depression
 Level 2
−8.44
<0.0001
−8.39
<0.0001
−8.41
<0.0001
−8.37
<0.0001
−8.43
<0.0001
−8.39
<0.0001
 Level 3
−16.68
<0.0001
−14.93
<0.0001
−16.63
<0.0001
−14.90
<0.0001
−16.79
<0.0001
−15.04
<0.0001
N3
−3.45
<0.0001
−3.39
<0.0001
3.43
0.0001
Observations
120,709
 
120,709
 
120,709
 
120,709
 
120,709
 
120,709
 
Adj R 2
0.2405
 
0.2406
 
0.2404
 
0.2406
 
0.2404
 
0.2406
 
F-tests have been performed between models with and without N3 term, no result is significant at p = 0.05 level
aReference group: self-care on level 1 or 2
Table 4 shows the coefficients produced by OLS based on aggregated data. The coefficients are monotonic for all dimensions in all models. For level 3, anxiety/depression had the greatest coefficient, followed by pain/discomfort and usual activities. For level 2, pain/discomfort had largest coefficient, followed by mobility and anxiety/depression. Overall, by excluding health states with fewer observations in the analyses, the adjusted R2 improved from Model 1M1 (0.91) to Model 1M3 (0.93).
Table 4
Regression analysis on VAS values, EQ-5D dimensions, aggregated data
 
Model 1M1a
Model 1M2b
Model 1M3c
Estimate
p value
Estimate
p value
Estimate
p value
Intercept
74.12
<0.0001
74.30
<0.0001
75.03
<0.0001
Mobility
 Level 2
−4.49
0.0002
−4.53
0.0003
−4.92
<0.0001
 Level 3
−5.88
0.0082
−4.77
0.0355
−4.63
0.0301
Self-care
 Level 2
−0.78
0.4754
−0.60
0.6025
−0.85
0.3903
 Level 3
−6.99
0.0028
−5.54
0.0264
−5.08
0.0397
Usual activities
 Level 2
−4.85
0.0001
−5.11
0.0001
−5.50
<0.0001
 Level 3
−9.79
<0.0001
−10.58
<0.0001
−11.04
<0.0001
Pain/discomfort
 Level 2
−6.36
<0.0001
−5.96
<0.0001
−5.57
<0.0001
 Level 3
−9.85
<0.0001
−10.23
<0.0001
−10.76
<0.0001
Anxiety/depression
 Level 2
−5.13
<0.0001
−5.48
<0.0001
−5.65
<0.0001
 Level 3
−12.39
<0.0001
−12.86
<0.0001
−15.27
<0.0001
Adjusted R2
0.9076
 
0.9136
 
0.9308
 
aHealth states with less than 20 observations are excluded (number of health states = 51)
bHealth states with less than 25 observations are excluded (number of health states = 47)
cHealth states with less than 30 observations are excluded (number of health states = 43)
The estimated values predicted by different models were compared with the observed values (Fig. 1), and goodness-of-fit statistics were reported (Table 5). For health states with 20 or more observations, for individual-level data, Models 3 and 4 performed the best; for aggregated data, it was Model 1M1.
Table 5
Spearman rank correlation coefficients (SCC) and mean absolute difference (MAD)
Observations in each health state
Number of health states
Individual-level data
Model 1
Model 2
Model 3
Model 4
Corr
MAD
Corr
MAD
Corr
MAD
Corr
MAD
n ≥ 1
167
0.686
7.55
0.676
7.51
0.687
7.53
0.677
7.48
n ≥ 20
51
0.945
4.14
0.946
3.97
0.945
4.10
0.947
3.92
n ≥ 25
47
0.950
4.07
0.951
3.91
0.951
4.03
0.952
3.87
n ≥ 30
43
0.952
3.90
0.951
3.84
0.953
3.85
0.952
3.78
Observations in each health state
Number of health states
Aggregated data
Model 1M1
Model 1M2
Model 1M3
Corr
MAD
Corr
MAD
Corr
MAD
n ≥ 1
167
0.668
7.02
0.643
8.83
0.655
8.88
n ≥ 20
51
0.960
2.30
0.871
6.13
0.864
6.72
n ≥ 25
47
0.962
2.23
0.871
6.13
0.865
6.70
n ≥ 30
43
0.964
1.99
0.861
5.95
0.855
6.63
The parsimony, monotonicity criteria and F-test (Table 3), and goodness-of-fit analyses (Table 5; Fig. 1) suggested that for the individual-level data, Model 3 was the best-fitting model; for the aggregated data, it was Model 1M1. For Model 3, the intercept was 82.4, corresponded to the observed mean value for health state 11111 (82.6). Coefficients for level 3 and level 2 were compared in absolute terms. For level 3, the greatest coefficient was seen for anxiety/depression (16.6), followed by pain/discomfort (14.0) and usual activities (11.2). For level 2, the greatest coefficient was seen for pain/discomfort (11.1), followed by anxiety/depression (8.4) and mobility (6.5). For Model 1M1, the intercept was 74.1, which was about 9 points lower than the observed value for 11111. For level 3, the greatest coefficient was seen for anxiety/depression (12.4), followed by pain/discomfort (9.9) and usual activities (9.8). For level 2, the greatest coefficient was seen for pain/discomfort (6.4), followed by anxiety/depression (5.1) and mobility (4.5).
Based on Model 3 (individual-level data) and Model 1M1 (aggregated data), VAS values for all the 243 EQ-5D-3L health states can be calculated. The VAS had the endpoints worst and best health state, which did not allow for anchoring between 0 (dead) and 1 (full health). For using VAS values in quality-adjusted life year (QALY) calculations, rescaling by the value for dead is needed. In this present study, the value for dead was obtained from the Household Health Survey 2010. The mean value for dead was 4.5. So as to rescale the estimated VAS values on a 0–1 metric, the formula (VASEstimated − deadmean)/(VAS11111 − deadmean) [11] was used. The estimated and rescaled VAS values for 243 EQ-5D health states are presented in Table S2 in online resource.

Discussion

Our study reports on the estimation of experience-based VAS values for EQ-5D-3L health states, using data from a large national cross-sectional population-based survey conducted in China. In the NHSS 2008, individuals reported their current health status using the EQ-5D descriptive system and valued their health using VAS. Appropriate sampling methods were used to recruit a national representative sample, which is the strength of our study. Furthermore, by utilising a previously obtained value for dead, we are able to transform values for all the 243 EQ-5D health states to a 0–1 scale (0 = dead; 1 = full health).
In China, 167 out of 243 EQ-5D health states were observed; this number is higher than that recorded in Sweden (148) [16] and UK (139) [20], where experience-based VAS values were also used to derive values for EQ-5D-3L health states. That more health states were observed in this study than in Sweden and UK, might be due to the larger sample size of the Chinese survey. In all countries, the most frequently occurring health state was 11111, followed by 11121. For China and UK, 11112 was the third; for Sweden, it was 11122. Nearly, 87 % of the respondents reported 11111 in China, higher than UK (45 %), Sweden (42 %) and Germany (66 %) [21]. The rate of respondents reporting no problems on EQ-5D dimensions in this present survey is roughly double the rate observed elsewhere and warrants further investigation.
Anxiety/depression has the greatest impact on overall HRQoL, as suggested in other studies in which experience-based values were used [16, 21, 22]. The difference between hypothetical values and experience-based values might be due to adaptation, contrast effects and shifting comparisons [19]. In the hypothetical valuation, the respondents might over-estimate loss in health as they underestimate the adaptation, and focus on transitory change from one health state to another [24]. Our study is in line with previous studies [15, 16, 18, 2228] and shows that the experience-based values tend to be higher than hypothetical values. The use of experience-based values in an intervention may seemingly lead to a smaller gain comparing with if values were based on hypothetical health states. If this is an underestimation of the gain depends on whose preferences are considered most suitable.
Several estimation models produced evidence of non-monotonicity, which was encountered by other studies as well [16, 20, 3739]. By merging self-care levels 1 and 2, the results are more logical; however, the index value is insensitive to the difference between levels 1 and 2 on self-care dimension. The reason for the observed non-monotonicity probably stems from construct–irrelevant variance or construct underrepresentation. We observed that a few respondents (1 %) reported problems on EQ-5D dimensions, yet had a VAS value at 100 (best heath); some respondents reported no problem, but reported a very low VAS value. This might due to misunderstanding, measurement noise, or that respondents actually valued own health state like that. As it is difficult to define what could be the most reasonable range of VAS value for a certain health state, we included all the answers in the analysis. Another issue is regarding the inconsistent pairs in the observed values, for example, 12222 is logically worse than 11222, but we observed a higher value for 12222 than 11222. We have identified all these kinds of logical inconsistent pairs, most of them were due to the small number of observation for that health state. That is also why we only report SCC and MAD for the health states with 20 or more observations. In our data, most inconsistency pairs came from the self-care dimension. The non-monotonicity for the self-care dimension might be due to the above reason, but also the skewness of the data, multi-collinearity and heteroscedasticity might contribute to that [20, 37].
The valuations for respondent’s own health seen in the data collected in this study suggest a truncated use of the VAS rating scale, with gaps evident at both the higher and lower range. Respondents who self-classify as being in the 11111 health state report a mean VAS rating that is some 17 points less than the defined value assigned to best imaginable health. Similarly, the high value for dead creates a 34 point gap between dead and worst imaginable health. This discontinuity in values might be a result of the valuation method itself, or a by-product of the descriptive classification. Whatever is the cause, it suggests that there are other mechanisms at work here that are yet poorly understood.
Taken together, these results suggest that there might be health domains additional to those specified as EQ-5D dimensions [20, 40], so that respondents might not consider that 11111 is in fact the best (or even best imaginable) health state [41]. The high proportion of respondents reporting 11111 in China might be attributable to many causes linked to the EQ-5D descriptive classification, for example at a purely technical level, the process of translation may have introduced incorrect meaning to the health problem descriptions. However, this seems unlikely although the hugely skewed distribution of responses would be consistent with the presence of an intrinsic design flaw.
Given the magnitude of the phenomenon, it may be that the model of health that provides the conceptual foundation of EQ-5D is simply not recognised by respondents with the Chinese or other East Asian culture background in the same way that it is by (say) respondents with purely Western European or North American culture background [3, 7, 40, 42, 43]. Culture can impact respondents answers from several perspectives [44]. For example, the numbers might be used differently cross different cultures, e.g., whether or not 100 on a VAS scale means the same thing across different cultures; or some items might function differently in different cultures, e.g., comparing with the English, Spanish and French respondents, the Chinese respondents consider the word ‘moderate problems’ representing more severe degree than other countries [45]. Whilst the EQ-5D dimensions themselves may appear to be relevant in describing health, the concept of varying degrees of problems within each dimension might not be recognised in the same way. Additional exploration of the concept of ‘health’ in China also seems necessary.
Both TTO and VAS have been adopted as valuation methods for eliciting values for the EQ-5D health states [11, 12]. VAS value sets are available for Belgium [46], Malaysia [47] and Europe [32]. VAS might be considered to be inferior to TTO, as it is not a choice based measure [2]; however, other views can be seen as well [48, 49]. If QALY is applied in non-economic evaluation, such as monitoring health status change of a population, then there is no requirement that the quality–adjustment factor must be a utility measure [20]. As stated by the EuroQoL Group that ‘the theoretical and empirical case for favouring one method of health state valuation over another is far from clear cut. In practice, there are currently no EQ-5D value set generated from SG methods, so for users the choice is between TTO and VAS’ [11]. The focus of the present study is to raise methodological issues, and further investigations are needed; hence, the rescaled values from this study should not be treated as EQ-5D tariff.
The presentation of results based both on the analysis of individual-level data and the aggregated data for observed health states raises important questions for analysts and decision-makers. Theoretically, the analyses based on individual-level data are expected to produce better results as they take each individual’s information into consideration. However, this approach relies upon there being reasonable parity amongst the health states under consideration. In valuation studies based on hypothetical health states, considerable care will be taken in selecting the states to ensure roughly comparable coverage per dimension/level. In a study based on experience-based health states, however, such control of design is infeasible. The fact that the vast majority of respondents report having no problem on any of the EQ-5D dimensions resulted in a skewed distribution of data, which in itself presents problems, especially with low frequencies of reported problems evident for some dimensions such as self-care and mobility. This has implications for the design of any study that seeks to establish experience-based values. Estimating a model based on aggregated data has the twin advantage of smoothing the variability of VAS values present for each state whilst at the same time reducing the potential swamping of minority health states by the overwhelming presence of the 11111 health state. Of course, there are drawbacks to this approach, notably in estimating mean values for health states with relatively few observations. This naturally raises the question as to how many observations are required in order to generate a ‘safe’ mean. We have tried some sensitive analysis in this study, however, to which extend it fits the requirement of power calculations based on statistical theory and how important that is, is for further research. But as long as we are cautious in our interpretation of results, we can still make progress with our understanding. In this study, for individual-level data, Model 3 performed best. However, by merging self-care levels 1 and 2, the index value is insensitive to the difference between levels 1 and 2 on self-care dimension, and for example, 11111 and 12111 would have the same index value [21]. For aggregated data, Model 1M1 performs best, however, the big gap between the estimated value and the observed value for the health state 11111 is problematic, which needs further investigation. The purpose of the present study was to help us gain a better understanding of the methodological issues that confront us in developing a mechanism for valuing EQ-5D health states using experience-based VAS values. Hence, it would be premature to suggest at this early stage that whether models based on individual-level or aggregated data should dominate.
Some general issues need to be addressed, limitations regarding sampling design, interviewer bias, definitions of socio-demographic factors and ceiling effect have been discussed elsewhere [8, 9]. Despite the above, there are limitations of modelling specification. As data were negatively skewed, the assumption of normality does not hold; though the estimates of parameters will still be consistent, the standard-error estimates will be inconsistent in small samples [50]. As there is correlation amongst the main effect dummy variables, models might suffer from multi-collinearity, heteroscedasticity and logically inconsistent in parameter estimates [16, 50, 51]. The potential extra health dimension might affect VAS values, and it might also be correlated with the EQ-5D dimensions, which can lead to bias in the estimations.
This study presents the feasibility of deriving an experience-based VAS values for EQ-5D-3L health states in China. The analysis of these VAS data raises more fundamental issues concerning the universal nature of the classification system and the extent to which Chinese respondents utilise the same concepts of health as defined by this classification system. Further investigation is needed regarding how the mode of administration, face-to-face interviews and the design of the VAS might influence responses. Additional analysis of these important population health survey data and qualitative studies may improve our understanding of these results but if, as seems probable, satisfactory explanations are not identified then more targeted studies of EQ-5D-3L focussing on these methodological issues would be justified.

Acknowledgments

We would like to thank the Chinese Ministry of Health for data collection and their support of data analysis work. We acknowledge financial support from the Swedish Research Council (Swedish Research Links programme 348-2009-6538), Karolinska Institutet’s Research Foundation Grants and the National Natural Science Foundation of China (Project 70873064, Project 2013BAI0402, Project 71373183). We are grateful for the valuable comments and suggestions received on earlier versions of this paper from the Equity and Health Policy Research Group at the Department of Public Health Sciences, Karolinska Institutet.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Onze productaanbevelingen

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Bijlagen

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatuur
1.
go back to reference Rabin, R., & de Charro, F. (2001). EQ-SD: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed Rabin, R., & de Charro, F. (2001). EQ-SD: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed
2.
go back to reference Drummond, M. F., Sculpher, M., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programs. New York: Oxford University Press. Drummond, M. F., Sculpher, M., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programs. New York: Oxford University Press.
3.
go back to reference Szende, A., & Williams, A. (2004). Measuring self-reported population health: an international perspective based on EQ-5D. Hungary: SpringMed Publishing. Szende, A., & Williams, A. (2004). Measuring self-reported population health: an international perspective based on EQ-5D. Hungary: SpringMed Publishing.
4.
go back to reference Devlin, N. J., Parkin, D., & Browne, J. (2010). Patient-reported outcome measures in the NHS: New methods for analysing and reporting EQ-5D data. Health Economics, 19(8), 886–905. Devlin, N. J., Parkin, D., & Browne, J. (2010). Patient-reported outcome measures in the NHS: New methods for analysing and reporting EQ-5D data. Health Economics, 19(8), 886–905.
5.
go back to reference Ting, R. Z. W., Nan, H., Yu, M. W. M., Kong, A. P. S., Ma, R. C. W., Wong, R. Y. M., et al. (2011). Diabetes-related distress and physical and psychological health in Chinese type 2 diabetic patients. Diabetes Care, 34(5), 1094–1096. Ting, R. Z. W., Nan, H., Yu, M. W. M., Kong, A. P. S., Ma, R. C. W., Wong, R. Y. M., et al. (2011). Diabetes-related distress and physical and psychological health in Chinese type 2 diabetic patients. Diabetes Care, 34(5), 1094–1096.
6.
go back to reference Zhao, F. L., Yue, M., Yang, H., Wang, T., Wu, J. H., & Li, S. C. (2010). Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome. Quality of Life Research, 19(9), 1273–1283.CrossRefPubMed Zhao, F. L., Yue, M., Yang, H., Wang, T., Wu, J. H., & Li, S. C. (2010). Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome. Quality of Life Research, 19(9), 1273–1283.CrossRefPubMed
7.
go back to reference Wang, H., Kindig, D. A., & Mullahy, J. (2005). Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Quality of Life Research, 14(1), 119–132.CrossRefPubMed Wang, H., Kindig, D. A., & Mullahy, J. (2005). Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Quality of Life Research, 14(1), 119–132.CrossRefPubMed
8.
go back to reference Sun, S., Chen, J., Johannesson, M., Kind, P., Xu, L., Zhang, Y., et al. (2011). Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Quality of Life Research, 20(3), 309–320.CrossRefPubMedCentralPubMed Sun, S., Chen, J., Johannesson, M., Kind, P., Xu, L., Zhang, Y., et al. (2011). Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Quality of Life Research, 20(3), 309–320.CrossRefPubMedCentralPubMed
9.
go back to reference Sun, S., Chen, J., Johannesson, M., Kind, P., Xu, L., Zhang, Y., et al. (2011). Regional differences in health status in China: Population health-related quality of life results from the National Health Services Survey 2008. Health & Place, 17(2), 671–680.CrossRef Sun, S., Chen, J., Johannesson, M., Kind, P., Xu, L., Zhang, Y., et al. (2011). Regional differences in health status in China: Population health-related quality of life results from the National Health Services Survey 2008. Health & Place, 17(2), 671–680.CrossRef
10.
go back to reference Wang, H. M., Patrick, D. L., Edwards, T. C., Skalicky, A. M., Zeng, H. Y., & Gu, W. W. (2011). Validation of the EQ-5D in a general population sample in urban China. Quality of Life Research, 21(1), 155–160. Wang, H. M., Patrick, D. L., Edwards, T. C., Skalicky, A. M., Zeng, H. Y., & Gu, W. W. (2011). Validation of the EQ-5D in a general population sample in urban China. Quality of Life Research, 21(1), 155–160.
11.
go back to reference Szende, A., Oppe, M., & Devlin, N. (Eds.). (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer. Szende, A., Oppe, M., & Devlin, N. (Eds.). (2007). EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer.
12.
go back to reference Xie, F., Gaebel, K., Perampaladas, K., Doble, B., & Pullenayegum, E. (2014). Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist. Medical Decision Making, 34(1), 8–20.CrossRefPubMed Xie, F., Gaebel, K., Perampaladas, K., Doble, B., & Pullenayegum, E. (2014). Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist. Medical Decision Making, 34(1), 8–20.CrossRefPubMed
13.
go back to reference Stolk, E. A., Oppe, M., Scalone, L., & Krabbe, P. F. (2010). Discrete choice modeling for the quantification of health states: The case of the EQ-5D. Value in Health, 13(8), 1005–1013.CrossRefPubMed Stolk, E. A., Oppe, M., Scalone, L., & Krabbe, P. F. (2010). Discrete choice modeling for the quantification of health states: The case of the EQ-5D. Value in Health, 13(8), 1005–1013.CrossRefPubMed
14.
go back to reference Dolan, P., & Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal, 118(525), 215–234.CrossRef Dolan, P., & Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal, 118(525), 215–234.CrossRef
15.
go back to reference De Wit, G. A., Busschbach, J. J. V., & De Charro, F. T. (2000). Sensitivity and perspective in the valuation of health status: Whose values count? Health Economics, 9(2), 109–126.CrossRefPubMed De Wit, G. A., Busschbach, J. J. V., & De Charro, F. T. (2000). Sensitivity and perspective in the valuation of health status: Whose values count? Health Economics, 9(2), 109–126.CrossRefPubMed
16.
go back to reference Burström, K., Sun, S., Gerdtham, U.-G., Henriksson, M., Johannesson, M., Levin, L.-Å., et al. (2014). Swedish experience-based value sets for EQ-5D health states. Quality of Life Research, 23(2), 431–442.CrossRefPubMedCentralPubMed Burström, K., Sun, S., Gerdtham, U.-G., Henriksson, M., Johannesson, M., Levin, L.-Å., et al. (2014). Swedish experience-based value sets for EQ-5D health states. Quality of Life Research, 23(2), 431–442.CrossRefPubMedCentralPubMed
17.
go back to reference Gandjour, A. (2010). Theoretical foundation of patient v. population preferences in calculating QALYs. Medical Decision Making, 30(4), E57–E63.CrossRefPubMed Gandjour, A. (2010). Theoretical foundation of patient v. population preferences in calculating QALYs. Medical Decision Making, 30(4), E57–E63.CrossRefPubMed
18.
go back to reference Burström, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy, 76(3), 359–370.CrossRefPubMed Burström, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy, 76(3), 359–370.CrossRefPubMed
19.
go back to reference Dolan, P. (2011). Thinking about it: Thoughts about health and valuing QALYs. Health Economics, 20(12), 1407–1416.CrossRefPubMed Dolan, P. (2011). Thinking about it: Thoughts about health and valuing QALYs. Health Economics, 20(12), 1407–1416.CrossRefPubMed
20.
go back to reference Kind, P. (2009). Valuing EQ-5D health states—A VASly simpler solution? In J. J. V. Busschbach, R. Rabin, & F. de Charro (Eds.), 24th Scientific plenary meeting of the EuroQol Group, Kijkduin-The Hague, the Netherlands, September 13–15, 2007: proceedings. Rotterdam: EuroQol Group Executive Office. Kind, P. (2009). Valuing EQ-5D health states—A VASly simpler solution? In J. J. V. Busschbach, R. Rabin, & F. de Charro (Eds.), 24th Scientific plenary meeting of the EuroQol Group, Kijkduin-The Hague, the Netherlands, September 1315, 2007: proceedings. Rotterdam: EuroQol Group Executive Office.
21.
go back to reference Leidl, R., & Reitmeir, P. (2011). A value set for the EQ-5D based on experienced health states. PharmacoEconomics, 29(6), 521–534.CrossRefPubMed Leidl, R., & Reitmeir, P. (2011). A value set for the EQ-5D based on experienced health states. PharmacoEconomics, 29(6), 521–534.CrossRefPubMed
22.
go back to reference Rand-Hendriksen, K., Augestad, L. A., Kristiansen, I. S., & Stavem, K. (2011). Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions. Quality of Life Research, 21(6), 1005–1012.CrossRefPubMed Rand-Hendriksen, K., Augestad, L. A., Kristiansen, I. S., & Stavem, K. (2011). Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions. Quality of Life Research, 21(6), 1005–1012.CrossRefPubMed
23.
go back to reference Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., et al. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy, 4(4), 201–208.CrossRefPubMed Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., et al. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy, 4(4), 201–208.CrossRefPubMed
24.
go back to reference Dolan, P. (2008). Developing methods that really do value the ‘Q’ in the QALY. Health Economics, Policy and Law, 3, 69–77. Dolan, P. (2008). Developing methods that really do value the ‘Q’ in the QALY. Health Economics, Policy and Law, 3, 69–77.
25.
go back to reference Mann, R., Brazier, J., & Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics, 18(3), 363–372.CrossRefPubMed Mann, R., Brazier, J., & Tsuchiya, A. (2009). A comparison of patient and general population weightings of EQ-5D dimensions. Health Economics, 18(3), 363–372.CrossRefPubMed
26.
go back to reference Ubel, P. A., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research, 12(6), 599–607.CrossRefPubMed Ubel, P. A., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research, 12(6), 599–607.CrossRefPubMed
27.
go back to reference Polsky, D., Willke, R. J., Scott, K., Schulman, K. A., & Glick, H. A. (2001). A comparison of scoring weights for EuroQol derived from patients and the general public. Health Economics, 10(1), 27–37.CrossRefPubMed Polsky, D., Willke, R. J., Scott, K., Schulman, K. A., & Glick, H. A. (2001). A comparison of scoring weights for EuroQol derived from patients and the general public. Health Economics, 10(1), 27–37.CrossRefPubMed
28.
go back to reference Zethraeus, N., & Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics, 8(6), 541–545.CrossRefPubMed Zethraeus, N., & Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics, 8(6), 541–545.CrossRefPubMed
29.
go back to reference Badia, X., Herdman, M., Dipstat, M. R., & Ohinmaa, A. (2001). Feasibility and Validity of the VAS and TTO for eliciting general population values for temporary health states: A comparative study. Health Services and Outcomes Research Methodology, 2(1), 51–65.CrossRef Badia, X., Herdman, M., Dipstat, M. R., & Ohinmaa, A. (2001). Feasibility and Validity of the VAS and TTO for eliciting general population values for temporary health states: A comparative study. Health Services and Outcomes Research Methodology, 2(1), 51–65.CrossRef
31.
go back to reference SAS Institute Inc. (2010). Base SAS 9. 2 procedures guide: Statistical procedures (3rd ed.). Cary, NC: SAS Institute. SAS Institute Inc. (2010). Base SAS 9. 2 procedures guide: Statistical procedures (3rd ed.). Cary, NC: SAS Institute.
32.
go back to reference Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., et al. (2003). A single European currency for EQ-5D health states. The European Journal of Health Economics, 4(3), 222–231.CrossRefPubMed Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., et al. (2003). A single European currency for EQ-5D health states. The European Journal of Health Economics, 4(3), 222–231.CrossRefPubMed
33.
go back to reference Hilbe, J. M. (2007). Negative binomial regression. Cambridge, New York: Cambridge University Press.CrossRef Hilbe, J. M. (2007). Negative binomial regression. Cambridge, New York: Cambridge University Press.CrossRef
34.
go back to reference Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica, 26(1), 24–36.CrossRef Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica, 26(1), 24–36.CrossRef
35.
go back to reference Gutenbrunner, C., & Jureckova, J. (1992). Regression rank scores and regression quantiles. The Annals of Statistics, 20(1), 305–330.CrossRef Gutenbrunner, C., & Jureckova, J. (1992). Regression rank scores and regression quantiles. The Annals of Statistics, 20(1), 305–330.CrossRef
37.
go back to reference Greiner, W., Claes, C., Busschbach, J. J. V., & Schulenburg, J. M. (2005). Validating the EQ-5D with time trade off for the German population. European Journal of Health Economics, 6(2), 124–130.CrossRefPubMed Greiner, W., Claes, C., Busschbach, J. J. V., & Schulenburg, J. M. (2005). Validating the EQ-5D with time trade off for the German population. European Journal of Health Economics, 6(2), 124–130.CrossRefPubMed
38.
go back to reference Lamers, L. M., McDonnell, J., Stalmeier, P. F. M., Krabbe, P. F. M., & Busschbach, J. J. V. (2006). The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15(10), 1121–1132. Lamers, L. M., McDonnell, J., Stalmeier, P. F. M., Krabbe, P. F. M., & Busschbach, J. J. V. (2006). The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15(10), 1121–1132.
39.
go back to reference Tongsiri, S., & Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value in Health, 14(8), 1142–1145. Tongsiri, S., & Cairns, J. (2011). Estimating population-based values for EQ-5D health states in Thailand. Value in Health, 14(8), 1142–1145.
40.
go back to reference Jo, M. W., Kim, S.-H., Minsu, O., & Lee, S. (2013). Exploratory study for dimensions of health related quality of life in South Korea. Presented at the 29th scientific plenary meeting of the EuroQol Group, Montreal, Canada. Jo, M. W., Kim, S.-H., Minsu, O., & Lee, S. (2013). Exploratory study for dimensions of health related quality of life in South Korea. Presented at the 29th scientific plenary meeting of the EuroQol Group, Montreal, Canada.
41.
go back to reference Luo, N., Liu, G., Li, M., Jin, X., & Guan, H. (2013). Estimating the time trade-off values of the EQ-5D-5L health states in urban China. Presented at the 29th scientific plenary meeting of the EuroQol Group, Montreal, Canada. Luo, N., Liu, G., Li, M., Jin, X., & Guan, H. (2013). Estimating the time trade-off values of the EQ-5D-5L health states in urban China. Presented at the 29th scientific plenary meeting of the EuroQol Group, Montreal, Canada.
42.
go back to reference Shaw, J. W., Johnson, J. A., Chen, S., Levin, J. R., & Coons, S. J. (2007). Racial/ethnic differences in preferences for the EQ-5D health states: results from the U.S. valuation study. Journal of Clinical Epidemiology, 60(5), 479–490.CrossRefPubMed Shaw, J. W., Johnson, J. A., Chen, S., Levin, J. R., & Coons, S. J. (2007). Racial/ethnic differences in preferences for the EQ-5D health states: results from the U.S. valuation study. Journal of Clinical Epidemiology, 60(5), 479–490.CrossRefPubMed
43.
go back to reference Leung, B., Luo, N., So, L., & Quan, H. (2007). Comparing three measures of health status (perceived health with Likert-type scale, EQ-5D, and number of chronic conditions) in Chinese and white Canadians. Medical Care, 45(7), 610–617.CrossRefPubMed Leung, B., Luo, N., So, L., & Quan, H. (2007). Comparing three measures of health status (perceived health with Likert-type scale, EQ-5D, and number of chronic conditions) in Chinese and white Canadians. Medical Care, 45(7), 610–617.CrossRefPubMed
45.
go back to reference Luo, N., Li, M., Chevalier, J., Lloyd, A., & Herdman, M. (2012). A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems. Quality of Life Research, 22, 2237–2243.CrossRefPubMed Luo, N., Li, M., Chevalier, J., Lloyd, A., & Herdman, M. (2012). A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems. Quality of Life Research, 22, 2237–2243.CrossRefPubMed
46.
go back to reference Cleemput, I., Kind, P., & Kesteloot, K. (2004). Re-scaling social preference data: implications for modelling. European Journal of Health Economics, 5(4), 290–298.CrossRefPubMed Cleemput, I., Kind, P., & Kesteloot, K. (2004). Re-scaling social preference data: implications for modelling. European Journal of Health Economics, 5(4), 290–298.CrossRefPubMed
47.
go back to reference Md Yusof, F. A., Goh, A., & Azmi, S. (2012). Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value in Health, 15(1), S85–S90.CrossRef Md Yusof, F. A., Goh, A., & Azmi, S. (2012). Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value in Health, 15(1), S85–S90.CrossRef
48.
go back to reference Parkin, D., & Devlin, N. (2006). Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Economics, 15(7), 653–664.CrossRefPubMed Parkin, D., & Devlin, N. (2006). Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Economics, 15(7), 653–664.CrossRefPubMed
49.
go back to reference Naylor, C., & Llewellyn-Thomas, H. (1998). Utilities and preferences for health states: time for a pragmatic approach? Journal of Health Services Research & Policy, 3(3), 129–131. Naylor, C., & Llewellyn-Thomas, H. (1998). Utilities and preferences for health states: time for a pragmatic approach? Journal of Health Services Research & Policy, 3(3), 129–131.
50.
go back to reference Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRefPubMed Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRefPubMed
51.
go back to reference Dolan, P. (1997). Modeling valuations for Euroqol health states. Medical Care, 35(11), 1095–1108.CrossRefPubMed Dolan, P. (1997). Modeling valuations for Euroqol health states. Medical Care, 35(11), 1095–1108.CrossRefPubMed
Metagegevens
Titel
Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China
Auteurs
Sun Sun
Jiaying Chen
Paul Kind
Ling Xu
Yaoguang Zhang
Kristina Burström
Publicatiedatum
01-03-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0793-6

Andere artikelen Uitgave 3/2015

Quality of Life Research 3/2015 Naar de uitgave